Using lung cancer screening data to improve COPD diagnosis
Leveraging Quantitative Imaging from Lung Cancer Screening to Create Tools to Confront COPD
This study is looking at how we can use lung cancer screening scans to better spot Chronic Obstructive Pulmonary Disease (COPD) in people who might have it but haven't been diagnosed yet, helping to catch it earlier and improve care for those at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10939807 on NIH RePORTER |
What this research studies
This research aims to enhance the identification of Chronic Obstructive Pulmonary Disease (COPD) by utilizing data from lung cancer screening CT scans. It addresses the challenge of underdiagnosis in COPD, which is often missed due to insufficient symptom sensitivity. By analyzing quantitative imaging data from low-dose computed tomography (LDCT) scans, the study seeks to develop tools that can better identify individuals at high risk for COPD. This approach leverages existing screening programs to improve patient outcomes and facilitate timely interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 50 to 80 years with a significant smoking history who are undergoing lung cancer screening.
Not a fit: Patients who do not smoke or have never smoked may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of COPD, ultimately improving patient management and outcomes.
How similar studies have performed: Previous research has shown promise in using imaging data for COPD detection, indicating that this approach could be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Han, Meilan K — University of Michigan at Ann Arbor
- Study coordinator: Han, Meilan K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.